Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.38 - $0.55 $3,344 - $4,840
8,801 Added 1.1%
809,403 $331,000
Q3 2021

Nov 12, 2021

BUY
$1.01 - $1.25 $244,692 - $302,837
242,270 Added 43.39%
800,602 $840,000
Q2 2021

Aug 13, 2021

BUY
$1.08 - $2.14 $229,434 - $454,619
212,439 Added 61.42%
558,332 $697,000
Q1 2021

May 12, 2021

BUY
$1.3 - $2.35 $18,424 - $33,306
14,173 Added 4.27%
345,893 $480,000
Q4 2020

Feb 12, 2021

BUY
$0.8 - $2.16 $61,059 - $164,859
76,324 Added 29.88%
331,720 $451,000
Q3 2020

Nov 13, 2020

SELL
$0.86 - $2.36 $7,181 - $19,706
-8,350 Reduced 3.17%
255,396 $237,000
Q2 2020

Aug 13, 2020

BUY
$0.7 - $1.58 $155,310 - $350,557
221,872 Added 529.86%
263,746 $400,000
Q1 2020

May 14, 2020

BUY
$0.48 - $2.19 $20,099 - $91,704
41,874 New
41,874 $29,000

About Cocrystal Pharma, Inc.


  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $14.3M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.